Using a cohort of breast cancer patients from the Clinical Proteomic Tumor Analysis Consortium (CPTAC), we analyzed whether C1orf50 mRNA and C1orf50 protein expression were correlated (r = 0.49, p < 0.001), and found a positive correlation (Fig. 2B). Here, C1orf50 is linked to breast cancer.